Method of treating inflammatory lung disease with suppressors of CpG oligonucleotides

US8043622B2 · kind B2 · utility

Assignee

• The United States of America as Represented by the Secretary of the Department of Health and Human Services · US

Inventors

• Dennis Klinman · Potomac, US
• Hiroshi Yamada · Kawasaki, JP

Key dates

• Filing date: Oct 7, 2003
• Grant date: Oct 25, 2011
• Expiry date: Feb 13, 2026

Classification

• Technology area (CPC C): Chemistry; Metallurgy
• CPC primary: C12N2310/151
• WIPO field: Pharmaceuticals
• WIPO sector: Chemistry

Abstract

The present disclosure relates to oligodeoxynucleotides that suppress an immune response. Methods are disclosed for inhibiting or treating inflammatory lung disease by administering a therapeutically effective amount of a suppressive oligodeoxynucleotide.